Redmile Group’s Ventyx Biosciences VTYX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.39M | Sell |
1,114,529
-455,264
| -29% | -$974K | 0.25% | 40 |
|
2025
Q1 | $1.81M | Buy |
1,569,793
+1,445,615
| +1,164% | +$1.66M | 0.17% | 51 |
|
2024
Q4 | $272K | Sell |
124,178
-1,983,037
| -94% | -$4.34M | 0.02% | 61 |
|
2024
Q3 | $4.59M | Sell |
2,107,215
-56,911
| -3% | -$124K | 0.27% | 47 |
|
2024
Q2 | $5M | Hold |
2,164,126
| – | – | 0.3% | 47 |
|
2024
Q1 | $11.9M | Buy |
2,164,126
+1,956,923
| +944% | +$10.8M | 0.44% | 51 |
|
2023
Q4 | $512K | Sell |
207,203
-722,697
| -78% | -$1.79M | 0.02% | 69 |
|
2023
Q3 | $32.3M | Sell |
929,900
-10,593
| -1% | -$368K | 1.54% | 21 |
|
2023
Q2 | $30.8M | Buy |
940,493
+124,719
| +15% | +$4.09M | 1.18% | 26 |
|
2023
Q1 | $27.3M | Sell |
815,774
-79,200
| -9% | -$2.65M | 1.19% | 30 |
|
2022
Q4 | $29.3M | Sell |
894,974
-470,026
| -34% | -$15.4M | 1.2% | 26 |
|
2022
Q3 | $47.7M | Buy |
+1,365,000
| New | +$47.7M | 1.85% | 19 |
|